Tübingen, Germany

Daniel Voss

USPTO Granted Patents = 11 

 

Average Co-Inventor Count = 4.2

ph-index = 6

Forward Citations = 199(Granted Patents)


Company Filing History:


Years Active: 2017-2025

Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Introduction

Daniel Voss, an accomplished inventor hailing from Tübingen, Germany, has made significant contributions to the field of biomedical research. With a remarkable portfolio of 10 patents to his name, Voss is particularly known for his work on developing vaccines against respiratory syncytial virus (RSV), a critical focus in public health.

Latest Patents

Voss's latest patents demonstrate his groundbreaking work in creating an mRNA-based vaccine for respiratory syncytial virus (RSV). This invention involves an mRNA sequence that encodes at least one antigenic peptide or protein associated with RSV infections. Further, the invention encompasses a composition made up of multiple mRNA sequences that serve the same purpose. The innovative approach aims to prepare a pharmaceutical composition, particularly a vaccine, for the prevention and treatment of RSV infections. Additionally, the patent details a method for using the mRNA sequence in the treatment or prophylaxis of RSV infections, marking a significant advancement in vaccine technology.

Career Highlights

Throughout his career, Daniel Voss has worked with prestigious companies, including CureVac AG and CureVac SE, where he has played a crucial role in vaccine development. His extensive experience in research and development has positioned him as a leading figure in the field.

Collaborations

Voss has collaborated with notable professionals like Thomas Kramps and Benjamin Petsch, contributing to a team effort that underscores the importance of collaborative innovation in scientific research. These partnerships have enabled the advancement of groundbreaking solutions in vaccine technology.

Conclusion

In summary, Daniel Voss stands out as a pivotal inventor in the realm of biomedical innovations, particularly with his remarkable advancements in RSV vaccines. His contributions have not only pushed the boundaries of scientific research but have also paved the way for potential breakthroughs in the prevention and treatment of viral infections. Voss’s unwavering commitment to innovation continues to inspire the scientific community as they strive for improved health outcomes worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…